[Federal Register Volume 81, Number 92 (Thursday, May 12, 2016)]
[Notices]
[Pages 29567-29568]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11141]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory Committee), National Institute for
Occupational Safety and Health (NIOSH), Docket Number CDC-2016-0036;
NIOSH 248-E
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 9:00 a.m.-5:00 p.m., June 2, 2016 (All times are
Eastern Daylight Time).
Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New
York, New York 10278. This meeting will also be available by telephone
and Web conference. Audio only will be available by telephone; video
will be available by Web conference. The USA toll-free, dial-in number
is 1-888-606-8411, and when prompted enter passcode--5064451. To view
the web conference, enter the following web address in your web
browser: https://odniosh.adobeconnect.com/wtchpstac/.
Public Comment Time and Date: 9:20 a.m.-9:50 a.m., June 2, 2016.
Please note that the public comment period ends at the time
indicated above or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up by
providing their name by mail, email, or telephone, at the addresses
provided below by May 29, 2016. Each commenter will be provided up to
five minutes for comment. A limited number of time slots are available
and will be assigned on a first come-first served basis. Written
comments will also be accepted from those unable to attend the public
session.
Status: Open to the public, limited only by the number of telephone
lines. The conference line will accommodate up to 50 callers; therefore
it is suggested that those interested in calling in to listen to the
committee meeting share a line when possible.
Background: The Advisory Committee was established by Title I of
the James Zadroga 9/11 Health and Compensation Act of 2010, Public Law
111-347 (January 2, 2011), amended by Public Law 114-113 (Dec. 18,
2015), adding Title XXXIII to the Public Health Service (PHS) Act
(codified at 42 U.S.C. 300mm to 300mm-61).
Purpose: The purpose of the Advisory Committee is to review
scientific and medical evidence and to make recommendations to the
World Trade Center (WTC) Program Administrator regarding additional WTC
Health Program eligibility criteria, potential additions to the list of
covered WTC-related health conditions, and research regarding certain
health conditions related to the September 11, 2001 terrorist attacks.
Title XXXIII of the PHS Act established the WTC Health Program within
the Department of Health and Human Services (HHS). The WTC Health
Program provides medical monitoring and treatment benefits to eligible
firefighters and related personnel, law enforcement officers, and
rescue, recovery, and cleanup workers who responded to the September
11, 2001, terrorist attacks in New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders), and to eligible persons who
were present in the dust or dust cloud on September 11, 2001 or who
worked, resided, or attended school, childcare, or adult daycare in the
New York City disaster area (survivors). Certain specific activities of
the WTC Program Administrator are reserved to the Secretary, HHS, to
delegate at her discretion; other WTC Program Administrator duties not
explicitly reserved to the Secretary, HHS, are assigned to the
Director, NIOSH. The administration of the Advisory Committee is left
to the Director of NIOSH in his role as WTC Program Administrator. CDC
and NIOSH provide funding, staffing, and administrative support
services for the Advisory Committee. The charter was reissued on May
12, 2015, and will expire on May 12, 2017.
Matters for Discussion: The Advisory Committee will address the new
responsibilities required under the reauthorization of the WTC Health
Program in the PHS Act. Specifically, the enhanced role of the STAC to
(1) make recommendations regarding the identification of individuals to
conduct independent peer reviews of the evidence that would be the
basis for issuing final rules to add a health condition to the List of
WTC-Related Health Conditions; and (2) review and evaluate the policies
and procedures in effect within the WTC Health Program that are used to
determine whether sufficient evidence is available to support adding a
non-cancer condition or type of cancer to the List of WTC-Related
Health Conditions.
The two policies can be found at: http://www.cdc.gov/wtc/policies.html. The agenda will include presentations on peer review and
the policies and procedures the WTC Health Program uses to add health
conditions to the list of covered conditions.
The agenda is subject to change as priorities dictate.
To view the notice, visit http://www.regulations.gov and enter CDC-
2016-0036 in the search field and click ``Search.''
Public Comment Sign-up and Submissions to the Docket: To sign up to
provide public comments or to submit comments to the docket, send
information to the NIOSH Docket Office by one of the following means:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS C-34,
1090 Tusculum Avenue, Cincinnati, Ohio 45226.
Email: [email protected].
Telephone: (513) 533-8611.
In the event an individual cannot attend, written comments may be
submitted. The comments should be
[[Page 29568]]
limited to two pages and submitted through http://www.regulations.gov
enter CDC-2016-0036 in the search field and click ``Search'' by May 29,
2016. Efforts will be made to provide the two-page written comments
received by the deadline above to the committee members before the
meeting. Comments in excess of two pages will be made publicly
available at http://www.regulations.gov (enter CDC-2016-0036 in the
search field and click ``Search'').
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to http://www.regulations.gov (enter CDC-2016-0036 in the search field and click
``Search'') within 60 days after the meeting. If a person making a
comment gives his or her name, no attempt will be made to redact that
name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include a
statement read at the start of the meeting stating that transcripts
will be posted and names of speakers will not be redacted. If
individuals in making a statement reveal personal information (e.g.,
medical information) about themselves, that information will not
usually be redacted. The CDC Freedom of Information Act coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and, if deemed appropriate, will redact such
information. Disclosures of information concerning third party medical
information will be redacted.
Contact Person for More Information: Paul J. Middendorf, Ph.D.,
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail
Stop E-20, Atlanta, Georgia 30345, telephone 1 (888) 982-4748; email:
[email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-11141 Filed 5-11-16; 8:45 am]
BILLING CODE 4163-18-P